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1  | INTRODUC TION
Age is a key risk factor for a number of retinal diseases including 
age- related macular degeneration (AMD), the leading cause of blind-
ness in higher income countries with ageing populations. One of the 
critical tissues involved in the pathogenesis of AMD is the retinal 
pigment epithelium (RPE), a monolayer of pigmented cells located be-
tween the vasculature of the choriocapillaris and the neurosensory 
retina. This unique environment presents the RPE with a number of 
important functions to support and maintain the visual processing 
of the retina, including transepithelial transport, absorption of light 
that has passed through the neurosensory retina, phagocytosis of 
photoreceptor outer segments and a fundamental role in maintain-
ing the retinoid cycle or visual cycle.1 Age- related changes in the 
RPE observed through microscopy include the accumulation of more 
numerous lysosomes, more remnants of phagosomes and morpho-
logical changes to mitochondria. However, the most characteristic 
physical sign of retinal ageing is the accumulation of lipoprotein- rich 
sub- RPE deposits also known as lipofuscin.2,3
Lipofuscin accumulation has been implicated in the pathogen-
esis of atrophic degeneration of the retina, such as dry age- related 
macular degeneration (AMD) and Stargardt disease.4,5 Key mech-
anistic insights into the accumulation of lipofuscin were gleaned 
from observations that its accumulation is dependent on dietary 
vitamin A6 and on a functioning visual cycle.7 This latter study 
showed that in mice with an impaired visual cycle, lacking both 
copies of the RPE65 gene, accumulation of lipofuscin in the RPE 
was abolished. Since then further evidence linking the visual cycle 
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Abstract
Ageing presents adverse effects on the retina and is the primary risk factor for age- 
related macular degeneration (AMD). We report the first RNA- seq analysis of age- 
related transcriptional changes in the human retinal pigment epithelium (RPE), the 
primary site of AMD pathogenesis. Whole transcriptome sequencing of RPE from 
human donors ranging in age from 31 to 93 reveals that ageing is associated with 
increasing transcription of main RPE- associated visual cycle genes (including LRAT, 
RPE65, RDH5, RDH10, RDH11; pathway enrichment BH- adjusted P = 4.6 × 10−6). This 
positive correlation is replicated in an independent set of 28 donors and a microarray 
dataset of 50 donors previously published. LRAT expression is positively regulated by 
retinoid by- products of the visual cycle (A2E and all- trans- retinal) involving modula-
tion by retinoic acid receptor alpha transcription factor. The results substantiate a 
novel age- related positive feedback mechanism between accumulation of retinoid 
by- products in the RPE and the up- regulation of visual cycle genes.
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with lipofuscin accumulation and retinal degeneration has been 
mounting. Impaired clearance of all- trans- retinal (atRAL), a prod-
uct of the photoisomerization stage of the visual cycle, has been 
shown to lead to lipofuscin deposits and retinal degeneration in 
mice.8- 11 If atRAL is not reduced back to retinol, it can inadver-
tently react to form condensation products such as di- retinoid- 
pyridinium- ethanolamine (A2E) and all- trans- retinal dimer. A2E is 
the product of a condensation reaction between two molecules 
of atRAL and one molecule of the common phospholipid, phospa-
tidylethanolamine (PE).12 The discovery that A2E is a constituent 
of lipofuscin13 provided further evidence linking the visual cycle 
with lipofuscin accumulation. The accumulation of A2E is detri-
mental to RPE cells, due to its amphiphilic structure and its photo- 
reactivity with blue light.14 Photo degradation of A2E generates 
dicarbonyls (glyoxal and methylglyoxal), which are known to mod-
ify proteins by forming advanced glycation end products (AGEs).15 
In turn, AGEs are well documented to be linked with ageing and a 
number of age- related pathologies including AMD.16
Quantitative analyses of gene expression changes are essential 
in furthering our understanding of the mechanisms underlying age-
ing and age- related diseases. With respect to the retina, microarray 
studies have been applied to characterize human RPE transcriptome 
17- 19 and more recently both bulk RNA- seq and single- cell RNA- seq 
have been used to study the neuroretina and RPE,20,21 with the lat-
ter studies having a particular emphasis on AMD. The current study, 
to our knowledge, is the first to use RNA- seq analysis to exclusively 
investigate the molecular changes underlying the ageing process in 
the human RPE.
2  | MATERIAL S AND METHODS
2.1 | Human donor eyes
RPE tissue was dissected from 41 human eyes donated for corneal 
transplantation and/or medical research through the Manchester 
Eye Bank, Manchester Royal Eye Hospital, UK, with consent 
by donors’ next of kin and in accordance with the tenets of the 
Declaration of Helsinki. Tissue collection and use were carried out 
under National Research Ethics Service approval obtained through 
Liverpool Research Ethics Committee and performed in accordance 
with HTA code of practice regarding utilization of human tissue. 
Samples from 13 donors ranging in age from 31 to 93 years were 
used for transcriptome profiling by RNA- seq and a further 28 sam-
ples from donors ranging in age from 45 to 88 years were used for 
validation by qPCR. Donors with recorded retinal pathology or with 
over 48 hours between death and RNA isolation were excluded.
2.2 | Microdissection of RPE/choroid, RPE 
isolation and RNA extraction
Following enucleation of the globes and removal of the an-
terior segment as part of the Corneal Transplant Service, the 
vitreous was removed and the posterior segment was rinsed 
in phosphate- buffered saline. The neural retina was peeled 
away with jeweller's forceps, and the RPE/choroid complex was 
teased from the sclera with the aid of a binocular dissecting mi-
croscope. The RPE- choroid was then subjected to a modified 
version of the Simultaneous RPE Isolation and RNA Stabilization 
(SRIRS) protocol22 with appropriate scaling up for human eyes 
involving placing the dissected RPE- choroid from one eye in 
2 mL RNAprotect Cell Reagent (Qiagen, West Sussex, UK). The 
solution was agitated for 15 minutes at room temperature al-
lowing the RPE cells to dissociate from the choroid. RNA was 
extracted using RNeasy Plus Mini Kit (Qiagen, West Sussex, 
UK). Purity, concentration and quality of RNA preparations 
were determined using a Nanodrop ND- 100 spectrophotometer 
(Labtech, Uckfield, East Sussex, UK) and a Bioanalyzer 2100 
(Agilent Technologies, Palo Alto, CA, USA), as well as by non- 
denaturing electrophoresis. All samples submitted for RNA- seq 
had A260/A280 ratios of the total RNA >2, the ratio of 28S/18S 
ribosomal RNA bands >1.8 and a RIN value >4. RPE purity was 
determined using the downstream RNA- seq analysis; if photore-
ceptor genes RHO, SAG, GNAT1, GNB1, GNGT1, PDE6A, PDE6B, 
PDE6G, ROM1, PRPH2, RCVRN, CNGA1, CNGB1 and GUCA1A 23 
cumulatively contributed to more than 1% of the total transcrip-
tome then the sample was excluded.
2.3 | RNA- seq analysis: cDNA library 
preparation and sequencing
Total RNA was processed by the Centre for Genomic Research, 
University of Liverpool, for library preparation and sequencing 
using the Illumina HiSeq 2000 platform. Ribosomal RNA (rRNA) 
was depleted from total RNA using the Ribo- Zero rRNA Removal 
kit (Epicentre, Madison, WI, USA). cDNA libraries were prepared 
with the ScriptSeq v2 RNA- Seq library preparation kit (Epicentre) 
by using 50 ng rRNA- depleted RNA as starting material. One lane 
of the Illumina HiSeq 2000 was used to sequence eight samples 
using paired- end sequencing (2 × 100 bp). The raw sequence data 
and processed counts data were deposited in the GEO repository 
(https://www.ncbi.nlm.nih.gov/geo/) under accession number 
GSE15 9435.
2.4 | Mapping and gene level analysis
The raw fastq files were trimmed for the presence of Illumina 
adapter sequences using Cutadapt version 1.2.1.24 This trimmed 
the 3' end of any reads which match the adapter sequence for 
3bp or more. The reads were further trimmed using Sickle version 
1.200 (window quality score > 20). Reads shorter than 10bp after 
trimming were removed. Quality control checks and measures 
were performed using FastQC.25 Mapping of the paired reads to 
the human reference genome (hg19) was performed using TopHat2 
version 1.3.0 KIM201, using default settings. Read counts were 
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measured with HTSeq,26 using the genome annotation by Ensembl 
(GRCh37.72) (n = 62,893).
Gene level analysis was carried out using DESeq2,27 which au-
tomatically filters out weakly expressed genes (to improve perfor-
mance by reducing multiple testing). There remained 20,154 genes 
after filtering. As we were interested in the effect of age on gene 
expression, DESeq2 was implemented to perform a linear regression 
between age and the read count of each gene. Age was the vari-
able of interest; however, we also included the additional covariates 
of gender and sequencing batch (1 or 2), making this a multi- factor 
design. As our independent variable (age) is continuous rather than 
dichotomous, we find it more appropriate to define a significantly 
correlated gene (SCG) rather than the conventional differentially 
expressed gene. An SCG is any gene with an expression level signifi-
cantly correlated (positively or negatively) with age. Specifically, we 
define an SCG as any gene with an expression level correlated with 
age such that its Benjamini- Hochberg (BH) adjusted P- value < .05 
and its |βage| > 0.025. Applying the standard adjusted P- value cut- 
off of .05 filters out 98% of all genes, then the βage cut- off of 0.025 
(which excludes genes with a small gradient) filters out less than 1% 
of the total number of genes.
2.5 | Validation of gene expression data by real- time 
quantitative PCR (qPCR)
To remove any remaining genomic DNA after RNA extraction, the 
independent set of 28 human donor samples were treated with 
DNA- free DNA Removal Kit (Invitrogen, UK). Complementary DNA 
was then synthesised with First Strand cDNA Synthesis Kit (Life 
Technologies/Thermo Fisher Scientific, UK), following the manu-
facturer's standard protocols. qPCR was performed with technical 
triplicates using a modified protocol described previously28 with 
MESA BLUE qPCR Mastermix Plus Kit for SYBR assay (Low ROX; 
Eurogentec, Southampton, UK) and a Stratagene MX3005P® qPCR 
System (Stratagene, La Jolla, CA, USA). The primer sets (Table S1) 
were custom synthesized (Eurogentec, Southampton, UK). The 
melt curve analysis and agarose gel electrophoresis were used to 
confirm the specificity of amplification reactions. The compara-
tive expression value of the gene of interest was calculated using 
the efficiency- corrected ddCt method, with normalization against 
three house- keeping genes (GAPDH, RPL5 and ACTB) for the in 
situ data and four house- keeping genes (GAPDH, RPL5, ACTB and 
TUBB) for the hfRPE in vitro studies. All house- keeping genes were 
selected and combined into a single standard using BestKeeper 
version1.29
2.6 | Gene set and pathway enrichment analyses
To test whether a KEGG pathway was enriched with SCGs we used 
the hypergeometric test, applying Benjamini- Hochberg adjust-
ment to cater for multiple testing. SCGs were rendered onto the 
relevant KEGG pathway map using the Pathview package in R/
Bioconductor.30 Gene set enrichment analysis (GSEA)31 was applied 
to a single pathway of the Reactome database.32
2.7 | Validation using publicly available microarray 
gene expression data
Gene Expression Omnibus dataset (GSE29801)33 was down-
loaded, and only patients with no ocular disease were selected. 
To combine both macular and periphery data, we implemented a 
mixed model for each gene where retinal position and age are the 
fixed effect predictors and the patient ID is the random effect 
predictor.
2.8 | In vitro measurement of effect of A2E, 
atRAL and Am580 on LRAT expression
Human foetal RPE (hfRPE) cells were grown to confluence in hfRPE 
media (15% FBS) and then maintained in 5% FBS as previously de-
scribed.34 Stock solutions (10 mmol/L) of Am580 (Sigma- Aldrich, 
Merck Life Science UK Limited, Gillingham, UK), all- trans- retinal 
(Sigma- Aldrich) and A2E (gift from T. Michael Redmond, synthesised 
as previously described35) were prepared in DMSO vehicle. A2E and 
Am580 were diluted to a final concentration of 25 μmol/L, and all- 
trans- retinal to 5 μmol/L, in hfRPE media containing 5% FBS. Cells 
were treated with a single dose of A2E, Am580, all- trans- retinal or 
vehicle control. All conditions were performed in triplicate wells. 
After the assigned time, RNA was extracted using RNAprotect Cell 
Reagent (Qiagen, West Sussex, UK) followed by standard RNeasy 
Plus Mini Kit (Qiagen, West Sussex, UK). All manipulations involving 
A2E, all- trans- retinal, Am580 and vehicle were conducted under dim 
(20- 40 lux) red (638 nm) safelight.
3  | RESULTS
3.1 | Overview of RNA sequencing data
The set of RPE expressed genes on which all following analyses 
were carried out comprised of 20,154 genes obtained through 
RNA- seq analysis of human donor RPE cells, followed by filter-
ing out weakly expressed genes by DESeq2. Out of this set, we 
defined a significantly correlated gene (SCG) to be one in which 
its expression level is correlated with age such that its Benjamini- 
Hochberg (BH) adjusted P- value < .05 and |βage| > 0.025, where 
βage represents the estimated change in gene expression per year 
of life. Using this definition, we determined a total of 822 SCGs 
(Table S2). Of these, the majority (n = 659) were protein coding. 
The non- coding SCGs included 93 long non- coding RNAs (lncR-
NAs), 35 pseudogenes and six small nuclear and small nucleolar 
RNAs (snRNAs and snoRNAs). The fact that the expression of 
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93 lncRNAs is significantly correlated with age corresponds with 
mounting evidence showing the importance of these RNAs in age-
ing.36 Of the total 822 SCGs, 447 were up- regulated with increas-
ing age (positively correlated) and 345 were down- regulated with 
increasing age (negatively correlated) (Figure 1A). These results 
demonstrate that the transcriptome of the human RPE exhibits 
significant age- related transcriptional changes.
3.2 | KEGG pathway enrichment analysis reveals 
multiple age- related pathways and identifies 
retinol metabolism to be the most significantly up- 
regulated pathway
We next performed pathway enrichment analysis using the 341 
human KEGG pathways, separately for positive SCGS and negative 
F I G U R E  1   RNA- seq of RPE reveals visual cycle genes are transcriptionally up- regulated with increasing human age. A, Volcano plot 
showing up- regulated SCGs in green and down- regulated in magenta. Genes in the retinol metabolism KEGG pathway are labelled. B, 
Pathway enrichment analysis of 341 KEGG pathways identifies retinol metabolism (map00830) to be the most significantly enriched with 
positively correlated SCGs. Pathways with a BH- adjusted P < .05 are highlighted in green. Fraction represents the number of SCGs in the 
pathway over the total number of genes in the pathway. C, KEGG pathway map of retinol metabolism (map00830), with positive SCGs 
highlighted in green. D, Scatter plots of the expression of 7 retinol metabolism genes from human donors (n = 13) ranging in age from 31 to 
93 years. Regression line (black) with 95% confidence interval (grey shading). E, qPCR validation of the positive correlation between age and 
transcription level of the core visual cycle genes (LRAT, RPE65 and RDH5). Validation carried out in a separate set of 28 human donors aged 
45 to 87 years. Regression line (black) with 95% confidence interval (grey shading); regression was weighted by the RNA integrity score of 
each sample shown by size of circle
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SCGs. For the positive SCGs, we found that the most significantly 
enriched pathway is the retinol metabolism (hsa00830) pathway, 
in which seven out of the 24 pathway genes are positive SCGs 
(BH- adjusted P = 2.58 × 10−5) (Figure 1B,C). The seven SCGs in 
this pathway are lecithin retinol acyltransferase (LRAT), retinoid 
isomerase (RPE65), three retinol dehydrogenases (RDH5, RDH10 
and RDH11), beta- carotene oxygenase 1 (BCO1) and a retinalde-
hyde dehydrogenase 3 (ALDH1A3) (Table 1). For each of these 
seven genes, the positive correlation between its expression and 
age of the 13 donors is shown in Figure 1D. The significant positive 
correlation with age of the expression of all these genes indicated 
that the retinoid cycle in the RPE is transcriptionally up- regulated 
with increasing human age. We further investigated the expres-
sion of three of these genes (LRAT, RPE65 and RDH5) by qPCR in 
an independent set of 28 human donors ranging in age from 41 
to 90 years. For all three genes, a significant positive correlation 
between donor age and RPE transcription level was determined 
(Figure 1E).
The second most significantly up- regulated pathway is cytokine- 
cytokine receptor interaction (hsa04060; BH- adjusted P = .0018) 
(Table 1). The genes up- regulated in this pathway include bone mor-
phogenetic proteins (BMP4, BMP6, BMP7, BMP8B) that are part of 
the transforming growth factor- beta superfamily, interleukins and 
chemokine receptors (IL16, IL17RB and CXCR2). This finding is con-
sistent with the increasing body of evidence of increased inflamma-
tion in the ageing RPE,37 and increased expression of the chemokine 
signalling in AMD.38 The third most significantly up- regulated path-
way is ether lipid metabolism (hsa00565). One of the most important 
classes of ether lipids is plasmalogens, and their function in the RPE 
may be involved in protection against oxidative stress; plasmalogen 
deficiency is associated with early onset retinal abnormalities and/
or retinopathy.39
Many pathways were found to be significantly down- regulated 
with age (Figure S1A; Table 2), the most significant one being pro-
tein digestion and absorption (Figure S1); this pathway is annotated 
in relation to nutritional homeostasis and as such this finding may 
reflect some similarities between the RPE and the intestinal epithe-
lial cells such as phagolysosome function. Interestingly, five of the 
eight significantly down- regulated genes in this pathway are colla-
gens (Table 2) and two in particular have been found to have rele-
vance for ocular ageing. Collagen type IV alpha 6 (COL4A6) is a major 
structural component of basement membranes and is found in most 
ocular basement membranes.40 Collagen type II alpha 1 (COL2A1) is 
a fibrillar collagen found in the vitreous humour and mutations in this 
gene are associated with Stickler syndrome in which patients suffer 
from ocular pathologies such as vitreous degeneration, high myopia, 
retinal detachment and cataracts.
The next most significantly down- regulated pathway is cell adhe-
sion molecules (CAMs) (hsa04514). This includes genes such as cad-
herins (CDH2), neurexins (CNTNAP2, NRXN1, NRXN2 and NRXN3) and 
other cell adhesion molecules (CADM1, L1CAM and NCAM1) (Table 2). 
Adhesion between RPE cells and the underlying Bruch's membrane 
is essential for RPE barrier and retinal support functions, and defects 
in adhesion are suspected to play a role in choroidal neovasculariza-
tion (CNV) initiation and progression.41 Previous research in our lab-
oratory found that advanced glycation end products (AGEs), which 
are known to accumulate on the Bruch's membrane with increasing 
age,16 reduce the transepithelial resistance of the RPE.42 Thus, taken 
together, we propose that with increasing age, the accumulated AGEs 
on the Bruch's membrane lead to decreased expression of CAMs 
TA B L E  1   KEGG pathways most significantly enriched with up- regulated SCGs





Gene symbols of SCGs in 
pathway
Retinol metabolism hsa00830 1.62 × 10−7 4.6 × 10−6 24 7 ALDH1A3, BCO1, LRAT, 
RDH10, RDH11, RDH5, 
RPE65
Cytokine- cytokine receptor 
interaction
hsa04060 .000298 .00783 113 10 ACVR1C, BMP4, BMP6, 
BMP7, BMP8B, CXCR2, 
GDF11, IL16, IL17RB, 
TNFRSF10C
Ether lipid metabolism hsa00565 .00078 .0166 27 4 ENPP2, PLA2G5, PLA2G7, 
SELENOI




hsa00564 .00346 .0561 71 6 GPAM, GPD1, PCYT1B, 
PLA1A, PLA2G5, SELENOI
Cysteine and methionine 
metabolism
hsa00270 .00424 .0628 39 4 BCAT1, CDO1, CTH, GOT2
Bile secretion hsa04976 .00527 .0691 41 4 SLC22A8, SLC4A2, 
SLC4A5, SLCO1A2
Mineral absorption hsa04978 .00527 .0691 41 4 ATP2B2, CLCN2, TRPM6, 
TRPM7
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by the RPE, which results in reduced transepithelial resistance. We 
also note that these molecules may be involved in maintaining at-
tachment of the RPE to the neurosensory retina, and that they are 
down- regulated with age may explain the increased risk of rheg-
matogenous retinal detachment in the elderly.43 It is also intriguing 
that cell adhesion molecules were found to be remarkably enriched 
in common protein networks shared between age- related diseases 
and longevity- associated processes.44 The fact that these adhesion 
molecules have been linked to longevity invites future research to 
explore whether restoring levels of these molecules may ameliorate 
the effects of ageing in the retina and elsewhere in the body.
Finally, we perform a KEGG pathway enrichment analysis of the 
full set of 822 SCGs (ie both positively and negatively correlated 
genes). The most significantly enriched pathway in this analysis is 
the Calcium signalling pathway (hsa04020), which is also one of the 
pathways previously observed when only considering the down- 
regulated genes (Figure S1A). Calcium is needed for a number of reg-
ulatory processes in RPE cells such as photoreceptor outer segment 
phagocytosis, transcellular fluid and ion transport, cell differentia-
tion and the control of gene expression.45 Our finding suggests that 
calcium signalling in the RPE may become dysregulated with increas-
ing age.
TA B L E  2   KEGG pathways most significantly enriched with down- regulated SCGs





Gene symbols of SCGs in 
pathway
Protein digestion and 
absorption




Cell adhesion molecules hsa04514 6.77 × 10−7 1.78x × 10−5 101 10 CADM1, CD274, CDH2, 
CNTNAP2, LRRC4C, 




hsa04080 1.46 × 10−6 3.56 × 10−5 109 10 CHRM4, DRD1, GABBR2, 
GRIA3, GRIA4, GRID2, 
GRIK1, GRM1, HTR2A, 
OXTR
Calcium signalling pathway hsa04020 4.95 × 10−6 .000113 148 11 CAMK4, DRD1, GRM1, 
HTR2A, MYLK4, NTRK3, 
OXTR, PDE1A, SLC8A1, 
SLC8A3, TRDN
Glutamatergic synapse hsa04724 7.43 × 10−6 .000158 83 8 ADCY5, DLGAP1, GRIA3, 
GRIA4, GRIK1, GRM1, 
KCNJ3, SLC38A1
Morphine addiction hsa05032 1.05 × 10−5 .000208 66 7 ADCY5, DRD1, GABBR2, 
KCNJ3, PDE11A, PDE1A, 
PDE4D
Amphetamine addiction hsa05031 1.10 × 10−5 .000208 48 6 ADCY5, CAMK4, DRD1, 
GRIA3, GRIA4, PPP1R1B
cAMP signalling pathway hsa04024 1.67 × 10−5 .000299 140 10 ADCY5, ATP1A2, CAMK4, 
DRD1, GABBR2, GRIA3, 
GRIA4, OXTR, PDE4D, 
PPP1R1B
Gap junction hsa04540 2.72 × 10−5 .000464 75 7 ADCY5, DRD1, GRM1, 
GUCY1A2, HTR2A, 
PRKG1, TUBB2B
F I G U R E  2   Reactome pathway analysis identifies a further set of visual cycle- related genes that have increased expression with 
increasing age. A, GSEA enrichment plot for the canonical retinoid cycle pathway (R- HSA- 2453902) from the Reactome database. B, Volcano 
plot showing expression levels of additional visual cycle genes identified from the Reactome pathway (RLBP1, RBP1 and TTR), as well as 
two other visual cycle genes previously documented (SOX9 and RGR). C, Scatter plots of the expression levels of five additional retinol 
metabolism genes, from human donors (n = 13) ranging in age from 31 to 93 years. Regression line (black) with 95% confidence interval (grey 
shading). D, Visual cycle diagram adapted from Reactome pathway browser.74 Significantly positively correlated genes, and complexes which 
include a SCG, are highlighted in green. Non- significant genes are in grey and other compounds which are not proteins are shown in white
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3.3 | Reactome pathway analysis confirms the 
visual cycle gene transcription up- regulation 
with age and identifies further significantly 
associated genes
From herein, we focus the analysis on the retinol metabolism 
(hsa00830) KEGG pathway due to both its novel link with ageing 
and its highest level of significance. Having identified this path-
way to be the most significantly up- regulated KEGG pathway, we 
sought to test this finding using the same data in a different path-
way database, namely the Reactome database. We identified the 
pathway most closely resembling the KEGG retinol metabolism to 
be the pathway named The canonical retinoid cycle in rods (twilight 
vision) [R- HSA- 2453902] (despite the mention of rods in its name, 
the description of the pathway states that this also takes place 
in the RPE). Here, we applied the Gene Set Enrichment Analysis 
(GSEA) approach and confirmed that this pathway is indeed 
significantly enriched (P = .00258) with a positive Normalized 
Enrichment Score (NES), confirming this pathway is up- regulated 
with age (Figure 2A). This analysis also revealed three further 
positive SCGs related to the retinoid cycle; these are retinol- 
binding protein (RBP1), retinaldehyde- binding protein 1 (RLBP1; 
also known as CRALBP) and transthyretin (TTR). For all three of 
these genes, the positive correlation between expression and age 
is highly significant, with a BH- adjusted P < .01 (Figure 2B- D). Two 
more genes related to the retinoid cycle known to be expressed 
in the RPE, namely RPE- retinal G protein- coupled receptor (RGR) 
and transcription factor SOX9 (Masuda et al 2014) were also found 
significantly positively correlated with age (Figure 2B,C). In total, 
the combined analysis found 12 visual cycle- associated genes 
transcriptionally up- regulated with increasing age.
Upon observing the SOX9 transcription factor is itself transcrip-
tionally up- regulated with age, we sought to investigate if its tar-
get genes were enriched within the 822 age- related SCGs. Using 
a transcription factor (TF) enrichment analysis tool called ChIP- X 
Enrichment Analysis 3 (ChEA3),46 we found the SOX9 target gene 
set was ranked 93rd out of all 1632 TFs (ie in the top 6%) using the 
mean rank across all ChEA3 libraries. When using only the GTEx co-
expression library the SOX9 gene set was ranked 3rd (top 0.2%), and 
this was highly significant (FDR = 2 × 10−11). We also noticed that the 
target genes of the Retinoic Acid Receptor Related Orphan Receptor 
B (RORB) transcription factor were also highly enriched within our 
SCGs; RORB was ranked 9th when using the mean rank of all libraries 
and 82nd in the GTEx coexpression library, which was also highly 
significant (FDR = 4.65 × 10−5).
3.4 | Validation of age- related increase in visual 
cycle gene transcription using previously published 
microarray expression data
Next, we sought to validate our results using publicly available ex-
pression data from an independent set of donors. For this purpose, 
we performed a search of all publicly available RPE transcriptome 
data and selected the study with the largest range of age of do-
nors with no ocular disease (used as controls in the respective 
study).33 This dataset contains microarray transcriptome data of 
the RPE from 50 normal human donors from the USA ranging in 
age from 10 to 93. All 50 donors have a sample from the macula, 
and 46 have also a sample from the periphery. All the 12 previ-
ously identified visual cycle- related SCGs were found to be posi-
tively correlated with age (β > 0) in this independent cohort, and 
10 of them were significant (P < .05) when combining both macu-
lar and periphery data (Figure 3A). All the core visual cycle- related 
genes (RPE65, LRAT and the three RDHs) were validated in this 
independent cohort; the two genes BCMO1 and ALDH1A3 that 
did not validate are more peripheral in the visual cycle biochem-
istry. We also assessed macular and periphery data separately 
and observed all 12 visual cycle- related genes are up- regulated 
with age in the macula alone, and likewise in the periphery alone 
(Figure 3B). Additionally, when comparing the effect of age in 
the macula versus the periphery, we detected positive correla-
tion between the respective transcriptional profiles of the visual 
cycle- related genes (Figure 3C). These results, as well as validating 
our primary finding, which was discovered from pooling RPE cells 
from the entire posterior retina, show that increasing age leads to 
increased visual cycle gene expression in both the macular and the 
periphery of the retina.
3.5 | LRAT transcription is positively regulated by 
A2E and atRAL treatment in hfRPE cells
The unexpected result of enhanced RPE expression of visual cycle- 
related genes with ageing prompted the investigation of the effect 
of visual cycle by- products, known to accumulate in the RPE with 
progressing age, on the transcription of these genes. We observed 
that LRAT mRNA expression showed a significant increase after 
8 hours of A2E treatment (Figure 4A). An even greater increase 
in LRAT expression was observed after 8 hour treatment with 
Am580, a selective retinoic acid receptor alpha (RARα) agonist 
(and resistant to rapid catabolism by enzymes of the cytochrome 
P450 CYP26 family). For Am580, further increases in LRAT expres-
sion were observed after 24 and 48 hours exposure with a linear 
trend. These results indicate that LRAT transcription is positively 
regulated in a RARα- mediated manner. The increased LRAT tran-
scription following 8 hour A2E exposure implies that A2E acts 
through RARα to increase LRAT expression. After 24 and 48 hours 
exposure to A2E, we did not observe a significant increase in LRAT 
expression. As it has previously been shown that a functional RPE 
lysosome is able to clear A2E,47,48 we propose that the observed 
transcriptional trend in the presence of A2E is explained by the 
RPE cells’ response to the A2E, which after a number of hours be-
gins to be cleared by the functional hfRPE lysosome. In contrast 
the synthetic retinoid Am580 is unable to be cleared, even by a 
functional lysosome. We also determined that LRAT expression 
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increased in hfRPE after exposure to all- trans- retinal (atRAL) 
(Figure 4B). We also tested the RPE65 and RDH5 expression after 
exposure to these retinoids in this experimental model but did not 
find evidence of up- regulation (data not shown), indicating that 
these two visual cycle genes are under different regulatory control 
compared with LRAT.
F I G U R E  3   Microarray data from an independent cohort GEO2980133 confirm that visual cycle genes exhibit increased expression with 
increasing age in both macular and periphery of the RPE. A, Scatter plots of the 12 previously identified visual cycle genes from donors with 
no ocular disease and with an age ranging from 9 to 93 years. Showing data from both the macular (in blue; n = 50) and the periphery (in 
orange; n = 46). To calculate the overall P- value (H0:βage = 0) combining both macular and periphery data, we implemented a mixed model 
for each gene. B, Volcano plots for macular and periphery RPE gene expression with respect to age. P values are adjusted for all genes in the 
genome using the Benjamini- Hochberg procedure. C, Showing the relationship of the gradient (βage) in the macular versus periphery for the 
whole RPE transcriptome. Visual cycle genes highlighted in black are all in the upper- right quadrant, indicative of similar age- related effect 
on their transcription in both regions. All data for this figure are selected from the Gene Expression Omnibus dataset GEO2980133
10  |     BUTLER ET aL.
4  | DISCUSSION
The transcriptome analysis performed by this study reveals im-
portant ways in which the human RPE changes with age. Most 
importantly, we discovered that the transcription level of genes in-
volved in the visual cycle are up- regulated with advancing age. To our 
knowledge, this is the first time that transcriptional up- regulation of 
this pathway has been reported in the ageing human RPE. However, 
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a strikingly similar observation has been reported in the rat where 
a RNA- seq transcriptome study of the rat retina found that the 
genes up- regulated in senescence accelerated rats ‘are unexpectedly 
associated with phototransduction’.49 In our study, we observe age- 
related increase in expression of the main visual cycle genes: LRAT, 
RPE65, RDH5, RDH10, RDH11, BCO1 and ALDH1A3. LRAT and RPE65 
act sequentially to catalyse the isomerization of all- trans- retinol to 
11- cis- retinol. The RDH genes operate together to catalyse the oxi-
dation of 11- cis- retinol to 11- cis- retinal,50 whereas BCO1 catalyses 
the synthesis of all- trans retinal. ALDH1A3 is a retinoic acid synthe-
sizing enzyme that may function in detoxifying retinal, either in a free 
or in a cellular retinol- binding protein form. We also find that a num-
ber of other genes related to the visual cycle are up- regulated with 
age including RGR, the retinoid carrier proteins (RBP1, RBPL1) and 
SOX9 a key transcription factor for the visual cycle regulation.51 We 
also note that one of the age- associated visual cycle genes, RDH5, 
was identified as one of the 15 putative causal genes for advanced 
AMD; a SNP (rs3138141) at the RDH5 locus identified from an AMD 
GWAS influences expression of this gene in the RPE.20 Another one 
of the genes that we identified, TTR, also contains a SNP (rs1667255) 
discovered by a GWAS; in this case, the association is with circulat-
ing retinol/vitamin A levels.52 Thus, we provide further support for 
prioritization of these genes for future AMD therapeutic research.
Our finding of increased visual cycle transcription with increased 
age substantiates another avenue of innovative therapeutic re-
search. There is a growing body of evidence supporting the use of 
pharmacological intervention to slow down the visual cycle in order 
to prevent lipofuscin accumulation.53 A properly functioning visual 
cycle gives rise to a number of natural by- products. One category of 
such by- products that have been shown to accumulate in aged wild- 
type mice eyes are retinyl esters.54 Also, bisretinoids, including the 
well- characterized A2E, are well documented to accumulate with 
increasing age in lipofuscin.13,55 Indeed the accumulation of these 
lipofuscin bisretinoids is dependent on a normal visual cycle,7 and 
mice with an impaired visual cycle (Rpe65- /- ) show less accumula-
tion and are more resistant to light- induced retinal degeneration.56 It 
was this work that first identified that the absence of retinaldehyde 
(both atRAL and 11- cis) drastically reduced formation of lipofuscin 
fluorophores. Consequently, pharmaceutical research to slow down 
this accumulation has begun with the aim of preventing dry AMD/
geographic atrophy.57 These pharmaceuticals known as visual cycle 
modulators (VCMs) include fenretinide, a synthetic retinoid, which 
reduces serum retinol and, therefore, inhibits the ocular uptake of 
all- trans- retinol, and emixustat hydrochloride, a small- molecule in-
hibitor of the visual cycle isomerase RPE65. Another class of such 
pharmaceuticals is represented by the RBP4 antagonists that disso-
ciate circulating RBP4- TTR- retinol complexes, reduce serum RBP4 
levels and inhibit bisretinoid synthesis in models of enhanced retinal 
lipofuscinogenesis.58
We further present evidence that the visual cycle gene LRAT is 
transcriptionally up- regulated in RPE in response to A2E, atRAL and 
Am580 (a RARα agonist) (Figure 4A,B). This finding is consistent with 
a number of observations from other studies that have studied the 
transcription of LRAT. In human prostate cells, retinoic acid recep-
tors (RARs) activate transcription of LRAT.59 Also in the neonatal, 
lung retinoic acid (RA) synergizes with vitamin A to enhance LRAT 
expression 60 and Am580 dramatically increases LRAT expression.61 
Dietary vitamin A has also been found to have a stimulatory effect 
on the expression of LRAT in the retina.62 Deprivation of vitamin A 
resulted in a significant reduction in LRAT expression in mice ret-
ina, whereas the LRAT expression was rescued in vitamin A deficient 
mice by intraperitoneal injection of RA.
Intriguingly, it has also been shown that RA is produced by the 
retina upon light exposure in mice.63 This corroborates well with 
recent in vitro evidence which found that all- trans- retinal is me-
tabolized by RPE into both all- trans- retinol through reduction (via 
conventional visual cycle), and into trans- RA through oxidation.64 
Furthermore, the RARα- selective agonist Am580, but not RXR ag-
onists, has also been shown to stimulate the expression of the SOX9 
transcription factor in a cartilage- derived cell line,65 various breast 
cancer cell lines66 and melanoma cells.67 Taken together this body of 
evidence suggests RA can accumulate in the RPE leading to activa-
tion of visual cycle expression through RAR and the SOX9 transcrip-
tion factors. This is in line with our TF analysis that found the SCGs 
are enriched within SOX9 and RORB target genes. A final piece of 
important evidence consistent with our data is that A2E and atRAL 
have the capacity to activate RAR,10 with A2E inducing sustained 
activation of RAR target genes in ARPE19 cells.68
Taken together, these observations evoke a mechanism to ex-
plain, at least in part, our primary finding that visual cycle tran-
scription increases with age. A2E and/or other visual cycle retinoid 
by- products accumulate with age in the RPE, where they act as 
RAR- ligands to stimulate transcription of LRAT. Collectively, the 
data suggest the existence of a novel mechanism involving a posi-
tive feedback loop between the transcription of visual cycle genes 
and the age- related accumulation of visual cycle by- products; 
F I G U R E  4   Visual cycle retinoid by- products positively regulate LRAT transcription in hfRPE cells. A, Two separate hfRPE cell lines were 
tested for LRAT transcription after treatment with A2E and Am580 for 8, 24 and 48 hours. B, A single hfRPE donor was tested for LRAT 
transcription after treatment with atRAL for 1, 8 and 24 hours. For all experiments, four house- keeping genes (ACTB, TUBB, RPL5 and 
GAPDH) were used as internal controls. All values are calculated relative to the control of the corresponding time- point. The data shown 
are mean ± standard error (for each donor, at each time- point, we performed a minimum of 3 replicates). Asterisks above bars represent 
significance levels: < 0.05 (*), < 0.01 (**), < 0.001 (***). C, Proposed mechanistic model illustrating the positive feedback effect of A2E upon 
the visual cycle. Solid broad arrows represent chemical reaction of the visual cycle, catalysed by the visual cycle enzymes. Narrow solid 
arrows represent non- enzymatic reaction. Dotted arrow represents positive effect of A2E upon transcription of LRAT
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age- related increased retinoid by- products accumulated from life- 
time visual cycle activity stimulate increased transcription of key 
visual cycle gene(s) (Figure 4C). It remains to be elucidated whether 
this mechanism arises solely as a consequence of the ageing process 
or whether it may be part of a coping, adaptive process to maintain 
vision. A compellingly similar mechanism has been proposed previ-
ously to explain the cytoprotective effect of a pharmacological in-
hibitor of CYP2C involved in RA metabolism.69 This mechanism calls 
for further research into new interventions to slow down the accu-
mulation of A2E/retinoid by- products, for instance new VCMs that 
inhibit RAR- activated gene transcription in the RPE.
The finding that there is a lack of spatial correlation between 
A2E and lipofuscin in the human retina, and that A2E is scarcely 
present in the macula70 casted some doubt over it being a direct con-
tributor to macular degeneration pathogenesis. However, this does 
not preclude A2E from being a transitory intermediate in this patho-
genic process; indeed studies have shown that bisretinoids undergo 
photo- oxidation induced degradation when irradiated with short- 
wavelength visible (blue) light.71 Photo- degradation of A2E and 
all- trans- retinal dimer generates the dicarbonyls glyoxal and meth-
ylglyoxal, known to form advanced glycation end products (AGEs).15 
This observation corresponds well with the fact that AGE accumula-
tion on the Bruch's membrane increases with age.16,72 Importantly, 
such accumulation of AGEs has been shown to affect RPE function42 
and has been linked with AMD.73 Thus the accumulation of certain 
atRAL condensation products followed by their photo- degradation, 
leading to AGE formation may represent one mechanism of atrophic 
macular degeneration.
In conclusion, even though the exact process by which accumu-
lated visual cycle by- products lead to retinal degeneration remains 
to be confirmed, our study, besides revealing the unexpected age- 
related increase in visual cycle gene transcription, presents further 
evidence that accumulated visual cycle by- products can actually 
activate visual cycle gene expression, thus exacerbating their own 
accumulation.
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